

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | heme biosynthetic process (GO:0006783) | 6.72972727 |
| 2 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.93737223 |
| 3 | DNA deamination (GO:0045006) | 5.93326892 |
| 4 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 5.83771403 |
| 5 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.79977798 |
| 6 | heme metabolic process (GO:0042168) | 5.60366079 |
| 7 | ribosomal small subunit assembly (GO:0000028) | 5.57442021 |
| 8 | porphyrin-containing compound biosynthetic process (GO:0006779) | 5.43298871 |
| 9 | erythrocyte maturation (GO:0043249) | 5.07895850 |
| 10 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.94273465 |
| 11 | tetrapyrrole biosynthetic process (GO:0033014) | 4.89699284 |
| 12 | proteasome assembly (GO:0043248) | 4.79478971 |
| 13 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.70534009 |
| 14 | negative regulation of interleukin-12 production (GO:0032695) | 4.67522162 |
| 15 | regulation of vitamin metabolic process (GO:0030656) | 4.55594636 |
| 16 | one-carbon compound transport (GO:0019755) | 4.48863794 |
| 17 | porphyrin-containing compound metabolic process (GO:0006778) | 4.48854443 |
| 18 | DNA replication initiation (GO:0006270) | 4.45300805 |
| 19 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.44438922 |
| 20 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.44386082 |
| 21 | response to peptidoglycan (GO:0032494) | 4.42584573 |
| 22 | regulation of mononuclear cell migration (GO:0071675) | 4.39778256 |
| 23 | protein autoprocessing (GO:0016540) | 4.35490025 |
| 24 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.33367717 |
| 25 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 4.29799647 |
| 26 | viral transcription (GO:0019083) | 4.26220726 |
| 27 | DNA replication checkpoint (GO:0000076) | 4.25839790 |
| 28 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.17123122 |
| 29 | translational termination (GO:0006415) | 4.16194892 |
| 30 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 4.12466975 |
| 31 | negative regulation of gluconeogenesis (GO:0045721) | 4.10910173 |
| 32 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 4.09733588 |
| 33 | deoxyribose phosphate biosynthetic process (GO:0046385) | 4.07987802 |
| 34 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 4.07987802 |
| 35 | deoxyribonucleotide biosynthetic process (GO:0009263) | 4.07945146 |
| 36 | CENP-A containing nucleosome assembly (GO:0034080) | 4.07557819 |
| 37 | regulation of podosome assembly (GO:0071801) | 4.04269887 |
| 38 | DNA strand elongation (GO:0022616) | 4.02214098 |
| 39 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.97310910 |
| 40 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.96762122 |
| 41 | regulation of chemokine biosynthetic process (GO:0045073) | 3.93156428 |
| 42 | telomere maintenance via recombination (GO:0000722) | 3.92774868 |
| 43 | glycosphingolipid catabolic process (GO:0046479) | 3.92581681 |
| 44 | chromatin remodeling at centromere (GO:0031055) | 3.89306132 |
| 45 | positive regulation of heat generation (GO:0031652) | 3.86268688 |
| 46 | adhesion of symbiont to host cell (GO:0044650) | 3.84903923 |
| 47 | virion attachment to host cell (GO:0019062) | 3.84903923 |
| 48 | NIK/NF-kappaB signaling (GO:0038061) | 3.84660769 |
| 49 | maturation of SSU-rRNA (GO:0030490) | 3.80933563 |
| 50 | oligosaccharide catabolic process (GO:0009313) | 3.78782113 |
| 51 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.76984644 |
| 52 | regulation of chronic inflammatory response (GO:0002676) | 3.69563786 |
| 53 | pseudouridine synthesis (GO:0001522) | 3.69478435 |
| 54 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.68784107 |
| 55 | myeloid dendritic cell differentiation (GO:0043011) | 3.68291759 |
| 56 | translational elongation (GO:0006414) | 3.68241203 |
| 57 | protein targeting to ER (GO:0045047) | 3.64857002 |
| 58 | cotranslational protein targeting to membrane (GO:0006613) | 3.64682600 |
| 59 | regulation of fever generation (GO:0031620) | 3.57893730 |
| 60 | erythrocyte development (GO:0048821) | 3.57236543 |
| 61 | metallo-sulfur cluster assembly (GO:0031163) | 3.56799338 |
| 62 | iron-sulfur cluster assembly (GO:0016226) | 3.56799338 |
| 63 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.54559105 |
| 64 | glycolipid catabolic process (GO:0019377) | 3.49474019 |
| 65 | adhesion of symbiont to host (GO:0044406) | 3.49256230 |
| 66 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.49105822 |
| 67 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.48537679 |
| 68 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.47971598 |
| 69 | protein localization to endoplasmic reticulum (GO:0070972) | 3.47950027 |
| 70 | ribosomal small subunit biogenesis (GO:0042274) | 3.46632423 |
| 71 | low-density lipoprotein particle clearance (GO:0034383) | 3.45421987 |
| 72 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.44838193 |
| 73 | mitotic recombination (GO:0006312) | 3.43859430 |
| 74 | ribosomal large subunit biogenesis (GO:0042273) | 3.43776257 |
| 75 | folic acid metabolic process (GO:0046655) | 3.42668782 |
| 76 | DNA replication-independent nucleosome organization (GO:0034724) | 3.42253876 |
| 77 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.42253876 |
| 78 | protein localization to endosome (GO:0036010) | 3.41049461 |
| 79 | regulation of mitochondrial translation (GO:0070129) | 3.40035415 |
| 80 | telomere maintenance via telomere lengthening (GO:0010833) | 3.39646977 |
| 81 | gas transport (GO:0015669) | 3.38571636 |
| 82 | regulation of protein heterodimerization activity (GO:0043497) | 3.36643090 |
| 83 | monocyte chemotaxis (GO:0002548) | 3.35650085 |
| 84 | macrophage activation involved in immune response (GO:0002281) | 3.35022733 |
| 85 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.33344787 |
| 86 | translational initiation (GO:0006413) | 3.32616402 |
| 87 | embryonic hemopoiesis (GO:0035162) | 3.31044518 |
| 88 | T-helper 1 type immune response (GO:0042088) | 3.29276406 |
| 89 | activation of MAPKKK activity (GO:0000185) | 3.28740281 |
| 90 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.27439110 |
| 91 | termination of RNA polymerase III transcription (GO:0006386) | 3.27439110 |
| 92 | viral life cycle (GO:0019058) | 3.27387677 |
| 93 | pigment biosynthetic process (GO:0046148) | 3.26551296 |
| 94 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.23567421 |
| 95 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.20783749 |
| 96 | cellular protein complex disassembly (GO:0043624) | 3.20325802 |
| 97 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.19388631 |
| 98 | translation (GO:0006412) | 3.16261787 |
| 99 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.14503635 |
| 100 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.14067095 |
| 101 | formation of translation preinitiation complex (GO:0001731) | 3.12769692 |
| 102 | decidualization (GO:0046697) | 3.11877228 |
| 103 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.10909456 |
| 104 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.10409471 |
| 105 | kinetochore assembly (GO:0051382) | 3.08051647 |
| 106 | cellular response to lipopolysaccharide (GO:0071222) | 3.07997006 |
| 107 | tetrapyrrole metabolic process (GO:0033013) | 3.07923080 |
| 108 | regulation of interferon-alpha production (GO:0032647) | 3.07748343 |
| 109 | ribosome biogenesis (GO:0042254) | 3.07273945 |
| 110 | ceramide catabolic process (GO:0046514) | 3.07122221 |
| 111 | rRNA modification (GO:0000154) | 3.05963245 |
| 112 | regulation of cholesterol storage (GO:0010885) | 3.04717013 |
| 113 | kinetochore organization (GO:0051383) | 3.04396987 |
| 114 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.01140839 |
| 115 | tRNA methylation (GO:0030488) | 3.00493488 |
| 116 | cell adhesion mediated by integrin (GO:0033627) | 3.00463285 |
| 117 | type I interferon signaling pathway (GO:0060337) | 3.00343197 |
| 118 | cellular response to type I interferon (GO:0071357) | 3.00343197 |
| 119 | myeloid dendritic cell activation (GO:0001773) | 2.98768047 |
| 120 | response to protozoan (GO:0001562) | 2.98588709 |
| 121 | neutrophil activation involved in immune response (GO:0002283) | 2.98301388 |
| 122 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.98279920 |
| 123 | germinal center formation (GO:0002467) | 2.97074858 |
| 124 | response to type I interferon (GO:0034340) | 2.96862427 |
| 125 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.94918606 |
| 126 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.94245132 |
| 127 | regulation of immunoglobulin secretion (GO:0051023) | 2.93524424 |
| 128 | cellular response to molecule of bacterial origin (GO:0071219) | 2.93406512 |
| 129 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.93281384 |
| 130 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.92328320 |
| 131 | rRNA processing (GO:0006364) | 2.91950241 |
| 132 | pinocytosis (GO:0006907) | 2.90662698 |
| 133 | negative regulation of lipid storage (GO:0010888) | 2.90018364 |
| 134 | response to thyroid hormone (GO:0097066) | 2.88996340 |
| 135 | cellular response to arsenic-containing substance (GO:0071243) | 2.87547176 |
| 136 | spliceosomal snRNP assembly (GO:0000387) | 2.87209785 |
| 137 | dendritic cell differentiation (GO:0097028) | 2.86704036 |
| 138 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.84903623 |
| 139 | amino sugar catabolic process (GO:0046348) | 2.84854984 |
| 140 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.81354901 |
| 141 | rRNA metabolic process (GO:0016072) | 2.80517806 |
| 142 | positive regulation of interleukin-6 production (GO:0032755) | 2.79061048 |
| 143 | pigment metabolic process (GO:0042440) | 2.78634325 |
| 144 | histone exchange (GO:0043486) | 2.78336450 |
| 145 | regulation of macrophage chemotaxis (GO:0010758) | 2.77453153 |
| 146 | defense response to protozoan (GO:0042832) | 2.76624931 |
| 147 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.75568188 |
| 148 | immunoglobulin mediated immune response (GO:0016064) | 2.74685229 |
| 149 | regulation of heat generation (GO:0031650) | 2.73959540 |
| 150 | erythrocyte differentiation (GO:0030218) | 2.72317879 |
| 151 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.72017752 |
| 152 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.71776494 |
| 153 | cell cycle G1/S phase transition (GO:0044843) | 2.71776494 |
| 154 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.71674060 |
| 155 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.71336783 |
| 156 | histone mRNA metabolic process (GO:0008334) | 2.70859311 |
| 157 | response to muramyl dipeptide (GO:0032495) | 2.69914639 |
| 158 | glial cell migration (GO:0008347) | 2.69897847 |
| 159 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.69823530 |
| 160 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.69208144 |
| 161 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.67954940 |
| 162 | protein targeting to mitochondrion (GO:0006626) | 2.67643179 |
| 163 | protein complex disassembly (GO:0043241) | 2.66853882 |
| 164 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.66820818 |
| 165 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.66712288 |
| 166 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.66712288 |
| 167 | mature B cell differentiation involved in immune response (GO:0002313) | 2.66654706 |
| 168 | barbed-end actin filament capping (GO:0051016) | 2.65951774 |
| 169 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.65727443 |
| 170 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.65712554 |
| 171 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.65595179 |
| 172 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.65595179 |
| 173 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.65595179 |
| 174 | modulation by symbiont of host cellular process (GO:0044068) | 2.65201462 |
| 175 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.64045028 |
| 176 | regulation of early endosome to late endosome transport (GO:2000641) | 2.62633146 |
| 177 | regulation of monocyte chemotaxis (GO:0090025) | 2.61815715 |
| 178 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.60628481 |
| 179 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.60466554 |
| 180 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.57925899 |
| 181 | eosinophil chemotaxis (GO:0048245) | 2.57300848 |
| 182 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.56092614 |
| 183 | positive regulation of type 2 immune response (GO:0002830) | 2.55052731 |
| 184 | detection of molecule of bacterial origin (GO:0032490) | 2.54292459 |
| 185 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.51879550 |
| 186 | cellular response to biotic stimulus (GO:0071216) | 2.51214134 |
| 187 | positive regulation by symbiont of host defense response (GO:0052509) | 2.49897744 |
| 188 | modulation by symbiont of host defense response (GO:0052031) | 2.49897744 |
| 189 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.49897744 |
| 190 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.49897744 |
| 191 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.49897744 |
| 192 | modulation by symbiont of host immune response (GO:0052553) | 2.49897744 |
| 193 | regulation of interleukin-6 production (GO:0032675) | 2.47693561 |
| 194 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.46864068 |
| 195 | hyaluronan catabolic process (GO:0030214) | 2.46486863 |
| 196 | positive regulation of acute inflammatory response (GO:0002675) | 2.46065450 |
| 197 | positive regulation of p38MAPK cascade (GO:1900745) | 2.45580244 |
| 198 | regulation of interleukin-12 production (GO:0032655) | 2.45405059 |
| 199 | granulocyte activation (GO:0036230) | 2.45001724 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.13758421 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 5.04890488 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.19406206 |
| 4 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.67302144 |
| 5 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.48793569 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.41658235 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.41598012 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.24487331 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.19430943 |
| 10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.05848932 |
| 11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.04525116 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.93671796 |
| 13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.84766125 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.81178747 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.80448566 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.66182057 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.63704184 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.60627793 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.56855245 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.56267585 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.55180043 |
| 22 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.51681574 |
| 23 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.44957507 |
| 24 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.43315291 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.41222265 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.39807361 |
| 27 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.39345970 |
| 28 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.38589150 |
| 29 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.37443474 |
| 30 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.29335783 |
| 31 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.27875113 |
| 32 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.26867787 |
| 33 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.18080453 |
| 34 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.17224638 |
| 35 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.15067393 |
| 36 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.13090548 |
| 37 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11536196 |
| 38 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.11122977 |
| 39 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.09810598 |
| 40 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.08028170 |
| 41 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.99268975 |
| 42 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.98997734 |
| 43 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.98177809 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.96232845 |
| 45 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.93957976 |
| 46 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.92367883 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.91711465 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.88775164 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87983128 |
| 50 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.85134131 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.84765950 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.81960841 |
| 53 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.80658591 |
| 54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79919134 |
| 55 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.79743655 |
| 56 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.77368518 |
| 57 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.77334729 |
| 58 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.75084463 |
| 59 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.73989923 |
| 60 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.72940112 |
| 61 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.72884391 |
| 62 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.70609978 |
| 63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.69416861 |
| 64 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67194284 |
| 65 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.65611855 |
| 66 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.63108931 |
| 67 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.62899653 |
| 68 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.61124667 |
| 69 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.58177134 |
| 70 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.55774644 |
| 71 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.53353114 |
| 72 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.52661345 |
| 73 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.51078007 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51015227 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.50282753 |
| 76 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48120033 |
| 77 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.46553356 |
| 78 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.46321238 |
| 79 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46294904 |
| 80 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46126283 |
| 81 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.43884917 |
| 82 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.43004934 |
| 83 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.42977780 |
| 84 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.40986662 |
| 85 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40948400 |
| 86 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.39927345 |
| 87 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.39661798 |
| 88 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.38798491 |
| 89 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.38341490 |
| 90 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.37867231 |
| 91 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36389356 |
| 92 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.35594030 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33733754 |
| 94 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.33675736 |
| 95 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32830162 |
| 96 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32076405 |
| 97 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.32039059 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31842310 |
| 99 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.31807078 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31026374 |
| 101 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.30154614 |
| 102 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.30035024 |
| 103 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.27042659 |
| 104 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25122972 |
| 105 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.24033138 |
| 106 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23886520 |
| 107 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.23070837 |
| 108 | MAF_26560356_Chip-Seq_TH1_Human | 1.23049396 |
| 109 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.21402046 |
| 110 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21360137 |
| 111 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.20046077 |
| 112 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.19005963 |
| 113 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18589509 |
| 114 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18491794 |
| 115 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.17808211 |
| 116 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.17062886 |
| 117 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.16728151 |
| 118 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.15761829 |
| 119 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15672113 |
| 120 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.15547779 |
| 121 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.15037156 |
| 122 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14826751 |
| 123 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14518287 |
| 124 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13096434 |
| 125 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.12147561 |
| 126 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.11984716 |
| 127 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.11840862 |
| 128 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.11727744 |
| 129 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.11727744 |
| 130 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11640580 |
| 131 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.10876550 |
| 132 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.10383857 |
| 133 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.09598528 |
| 134 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.09568116 |
| 135 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07518633 |
| 136 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07366975 |
| 137 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07246679 |
| 138 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.06899365 |
| 139 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05782979 |
| 140 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05112740 |
| 141 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04905532 |
| 142 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.04329465 |
| 143 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03939333 |
| 144 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01789662 |
| 145 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01487932 |
| 146 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01454817 |
| 147 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.00832693 |
| 148 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.00602285 |
| 149 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.00519924 |
| 150 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99902783 |
| 151 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.99298744 |
| 152 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.95720374 |
| 153 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.95196220 |
| 154 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.94197068 |
| 155 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.93485414 |
| 156 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.92525400 |
| 157 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.92068204 |
| 158 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.91879183 |
| 159 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.90982663 |
| 160 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.89224044 |
| 161 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.87987048 |
| 162 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.87377384 |
| 163 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.87322477 |
| 164 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87144404 |
| 165 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.86751460 |
| 166 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.86539717 |
| 167 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86464820 |
| 168 | MYC_22102868_ChIP-Seq_BL_Human | 0.85223839 |
| 169 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.85063570 |
| 170 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.84772749 |
| 171 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.84584862 |
| 172 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.83762968 |
| 173 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.82261324 |
| 174 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81904785 |
| 175 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80275165 |
| 176 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.77740877 |
| 177 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.76862209 |
| 178 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.76556193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004147_increased_porphyrin_level | 6.49675782 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 6.46981520 |
| 3 | MP0003303_peritoneal_inflammation | 4.78701428 |
| 4 | MP0005058_abnormal_lysosome_morphology | 4.32188292 |
| 5 | MP0004510_myositis | 3.52654346 |
| 6 | MP0009840_abnormal_foam_cell | 3.52360146 |
| 7 | MP0003693_abnormal_embryo_hatching | 3.36891732 |
| 8 | MP0005397_hematopoietic_system_phenotyp | 3.29959119 |
| 9 | MP0001545_abnormal_hematopoietic_system | 3.29959119 |
| 10 | MP0006082_CNS_inflammation | 3.24815451 |
| 11 | MP0002396_abnormal_hematopoietic_system | 2.95112274 |
| 12 | MP0003111_abnormal_nucleus_morphology | 2.76838479 |
| 13 | MP0005275_abnormal_skin_tensile | 2.76695626 |
| 14 | MP0004957_abnormal_blastocyst_morpholog | 2.71606637 |
| 15 | MP0010094_abnormal_chromosome_stability | 2.70463336 |
| 16 | MP0008057_abnormal_DNA_replication | 2.68202743 |
| 17 | MP0000490_abnormal_crypts_of | 2.63635536 |
| 18 | MP0002132_abnormal_respiratory_system | 2.58575157 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.54052481 |
| 20 | MP0008058_abnormal_DNA_repair | 2.51336095 |
| 21 | MP0002139_abnormal_hepatobiliary_system | 2.45396945 |
| 22 | MP0008438_abnormal_cutaneous_collagen | 2.38657875 |
| 23 | MP0003172_abnormal_lysosome_physiology | 2.37044916 |
| 24 | MP0005451_abnormal_body_composition | 2.30548184 |
| 25 | MP0003075_altered_response_to | 2.29649117 |
| 26 | MP0003453_abnormal_keratinocyte_physiol | 2.27971110 |
| 27 | MP0003077_abnormal_cell_cycle | 2.09296026 |
| 28 | MP0008007_abnormal_cellular_replicative | 1.99631544 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.96333564 |
| 30 | MP0001790_abnormal_immune_system | 1.96270045 |
| 31 | MP0005387_immune_system_phenotype | 1.96270045 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.94642747 |
| 33 | MP0003186_abnormal_redox_activity | 1.91967225 |
| 34 | MP0000604_amyloidosis | 1.89016948 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.88488464 |
| 36 | MP0009278_abnormal_bone_marrow | 1.84747226 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.82754937 |
| 38 | * MP0009764_decreased_sensitivity_to | 1.82200211 |
| 39 | MP0001542_abnormal_bone_strength | 1.78128653 |
| 40 | MP0002998_abnormal_bone_remodeling | 1.73968451 |
| 41 | MP0003448_altered_tumor_morphology | 1.73884373 |
| 42 | MP0005501_abnormal_skin_physiology | 1.73571723 |
| 43 | MP0005503_abnormal_tendon_morphology | 1.65626995 |
| 44 | MP0003724_increased_susceptibility_to | 1.64946353 |
| 45 | MP0005257_abnormal_intraocular_pressure | 1.63843079 |
| 46 | MP0000685_abnormal_immune_system | 1.55721353 |
| 47 | MP0003806_abnormal_nucleotide_metabolis | 1.54004950 |
| 48 | MP0008775_abnormal_heart_ventricle | 1.53626902 |
| 49 | MP0009379_abnormal_foot_pigmentation | 1.53218217 |
| 50 | MP0008004_abnormal_stomach_pH | 1.50177727 |
| 51 | MP0003091_abnormal_cell_migration | 1.48658345 |
| 52 | * MP0002723_abnormal_immune_serum | 1.48421432 |
| 53 | MP0003786_premature_aging | 1.45576148 |
| 54 | MP0002060_abnormal_skin_morphology | 1.45310734 |
| 55 | MP0010352_gastrointestinal_tract_polyps | 1.44966293 |
| 56 | MP0001853_heart_inflammation | 1.39920835 |
| 57 | MP0002877_abnormal_melanocyte_morpholog | 1.39669145 |
| 58 | * MP0001845_abnormal_inflammatory_respons | 1.37684274 |
| 59 | * MP0008469_abnormal_protein_level | 1.37650824 |
| 60 | MP0001243_abnormal_dermal_layer | 1.36899700 |
| 61 | MP0002102_abnormal_ear_morphology | 1.35345107 |
| 62 | MP0005636_abnormal_mineral_homeostasis | 1.35136302 |
| 63 | MP0002332_abnormal_exercise_endurance | 1.34978563 |
| 64 | MP0008932_abnormal_embryonic_tissue | 1.34678030 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 1.31227310 |
| 66 | MP0005166_decreased_susceptibility_to | 1.28246461 |
| 67 | MP0002796_impaired_skin_barrier | 1.28085011 |
| 68 | MP0003950_abnormal_plasma_membrane | 1.27526281 |
| 69 | MP0001849_ear_inflammation | 1.27279134 |
| 70 | MP0001800_abnormal_humoral_immune | 1.24114552 |
| 71 | * MP0006054_spinal_hemorrhage | 1.21842748 |
| 72 | MP0008260_abnormal_autophagy | 1.18772986 |
| 73 | MP0006036_abnormal_mitochondrial_physio | 1.16595567 |
| 74 | MP0003941_abnormal_skin_development | 1.15175371 |
| 75 | MP0009931_abnormal_skin_appearance | 1.14307700 |
| 76 | MP0005165_increased_susceptibility_to | 1.13882684 |
| 77 | MP0005310_abnormal_salivary_gland | 1.13211256 |
| 78 | MP0005174_abnormal_tail_pigmentation | 1.12578118 |
| 79 | * MP0002398_abnormal_bone_marrow | 1.12332115 |
| 80 | MP0000858_altered_metastatic_potential | 1.10941053 |
| 81 | MP0004947_skin_inflammation | 1.09805026 |
| 82 | MP0000313_abnormal_cell_death | 1.06653125 |
| 83 | MP0004808_abnormal_hematopoietic_stem | 1.06272342 |
| 84 | MP0000350_abnormal_cell_proliferation | 1.04711520 |
| 85 | MP0003690_abnormal_glial_cell | 1.04610998 |
| 86 | MP0005595_abnormal_vascular_smooth | 1.02163252 |
| 87 | MP0002019_abnormal_tumor_incidence | 1.01850454 |
| 88 | MP0001958_emphysema | 0.99765963 |
| 89 | MP0003329_amyloid_beta_deposits | 0.98788012 |
| 90 | * MP0002722_abnormal_immune_system | 0.98001336 |
| 91 | MP0000689_abnormal_spleen_morphology | 0.97306345 |
| 92 | MP0003195_calcinosis | 0.95874137 |
| 93 | MP0010771_integument_phenotype | 0.94995393 |
| 94 | * MP0002429_abnormal_blood_cell | 0.94918523 |
| 95 | MP0001216_abnormal_epidermal_layer | 0.94225888 |
| 96 | MP0009785_altered_susceptibility_to | 0.93424800 |
| 97 | MP0003566_abnormal_cell_adhesion | 0.92494043 |
| 98 | MP0005076_abnormal_cell_differentiation | 0.92009761 |
| 99 | MP0002933_joint_inflammation | 0.91662635 |
| 100 | MP0002095_abnormal_skin_pigmentation | 0.91584830 |
| 101 | MP0008789_abnormal_olfactory_epithelium | 0.91434279 |
| 102 | MP0001835_abnormal_antigen_presentation | 0.90771587 |
| 103 | MP0003279_aneurysm | 0.90557537 |
| 104 | MP0004858_abnormal_nervous_system | 0.89670932 |
| 105 | MP0000566_synostosis | 0.89564294 |
| 106 | MP0003763_abnormal_thymus_physiology | 0.89469120 |
| 107 | MP0000343_altered_response_to | 0.89440385 |
| 108 | MP0010307_abnormal_tumor_latency | 0.88881263 |
| 109 | MP0002148_abnormal_hypersensitivity_rea | 0.88711939 |
| 110 | MP0003795_abnormal_bone_structure | 0.85556387 |
| 111 | MP0005075_abnormal_melanosome_morpholog | 0.84880687 |
| 112 | MP0002405_respiratory_system_inflammati | 0.82379276 |
| 113 | MP0000920_abnormal_myelination | 0.82323048 |
| 114 | MP0009763_increased_sensitivity_to | 0.81899307 |
| 115 | MP0005671_abnormal_response_to | 0.81541693 |
| 116 | MP0002098_abnormal_vibrissa_morphology | 0.75420367 |
| 117 | MP0002896_abnormal_bone_mineralization | 0.74576668 |
| 118 | MP0001533_abnormal_skeleton_physiology | 0.74184793 |
| 119 | MP0005025_abnormal_response_to | 0.73943882 |
| 120 | MP0000249_abnormal_blood_vessel | 0.73910019 |
| 121 | MP0004272_abnormal_basement_membrane | 0.73276824 |
| 122 | MP0003718_maternal_effect | 0.72958310 |
| 123 | MP0003828_pulmonary_edema | 0.70797085 |
| 124 | MP0005164_abnormal_response_to | 0.70098307 |
| 125 | MP0001188_hyperpigmentation | 0.69263904 |
| 126 | MP0004883_abnormal_blood_vessel | 0.68948889 |
| 127 | MP0003634_abnormal_glial_cell | 0.67037743 |
| 128 | MP0001663_abnormal_digestive_system | 0.66987802 |
| 129 | MP0002254_reproductive_system_inflammat | 0.66727006 |
| 130 | MP0005390_skeleton_phenotype | 0.65504138 |
| 131 | MP0000358_abnormal_cell_content/ | 0.64999483 |
| 132 | MP0000750_abnormal_muscle_regeneration | 0.64383078 |
| 133 | MP0003567_abnormal_fetal_cardiomyocyte | 0.64234984 |
| 134 | MP0010155_abnormal_intestine_physiology | 0.64192990 |
| 135 | MP0002006_tumorigenesis | 0.63804634 |
| 136 | * MP0000716_abnormal_immune_system | 0.63370694 |
| 137 | MP0006035_abnormal_mitochondrial_morpho | 0.63205179 |
| 138 | MP0001191_abnormal_skin_condition | 0.62301300 |
| 139 | MP0005464_abnormal_platelet_physiology | 0.62102117 |
| 140 | MP0002452_abnormal_antigen_presenting | 0.61992510 |
| 141 | MP0005000_abnormal_immune_tolerance | 0.61909570 |
| 142 | MP0005023_abnormal_wound_healing | 0.61520120 |
| 143 | * MP0000703_abnormal_thymus_morphology | 0.60973939 |
| 144 | MP0008874_decreased_physiological_sensi | 0.60764534 |
| 145 | * MP0000767_abnormal_smooth_muscle | 0.59753479 |
| 146 | MP0000371_diluted_coat_color | 0.59738298 |
| 147 | MP0003436_decreased_susceptibility_to | 0.58493233 |
| 148 | MP0000372_irregular_coat_pigmentation | 0.57837420 |
| 149 | MP0005508_abnormal_skeleton_morphology | 0.57585935 |
| 150 | MP0002089_abnormal_postnatal_growth/wei | 0.57312871 |
| 151 | MP0002420_abnormal_adaptive_immunity | 0.57177116 |
| 152 | MP0001819_abnormal_immune_cell | 0.56970421 |
| 153 | MP0000749_muscle_degeneration | 0.56284179 |
| 154 | MP0000465_gastrointestinal_hemorrhage | 0.55092384 |
| 155 | MP0002419_abnormal_innate_immunity | 0.54151383 |
| 156 | * MP0002080_prenatal_lethality | 0.53247475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal number of erythroid precursors (HP:0012131) | 7.96790422 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 7.44018946 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 7.17127202 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.17127202 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.17127202 |
| 6 | Poikilocytosis (HP:0004447) | 4.86836282 |
| 7 | Dysostosis multiplex (HP:0000943) | 4.66706859 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 4.63828331 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 4.58124695 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 4.53059584 |
| 11 | Birth length less than 3rd percentile (HP:0003561) | 4.44320879 |
| 12 | Loss of speech (HP:0002371) | 4.34651464 |
| 13 | Reticulocytosis (HP:0001923) | 4.30699285 |
| 14 | Abnormality of reticulocytes (HP:0004312) | 4.28281995 |
| 15 | Pallor (HP:0000980) | 4.26041921 |
| 16 | Reticulocytopenia (HP:0001896) | 4.23984590 |
| 17 | Petechiae (HP:0000967) | 4.23331158 |
| 18 | Short middle phalanx of the 5th finger (HP:0004220) | 4.16982270 |
| 19 | Nuclear cataract (HP:0100018) | 4.16614978 |
| 20 | Disinhibition (HP:0000734) | 3.85826543 |
| 21 | Abnormality of macrophages (HP:0004311) | 3.79246350 |
| 22 | Acanthocytosis (HP:0001927) | 3.77328917 |
| 23 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.74092401 |
| 24 | Neurofibrillary tangles (HP:0002185) | 3.74079585 |
| 25 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.64946200 |
| 26 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.64946200 |
| 27 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.64946200 |
| 28 | Aplastic anemia (HP:0001915) | 3.64195288 |
| 29 | Increased serum ferritin (HP:0003281) | 3.62273315 |
| 30 | Axonal loss (HP:0003447) | 3.58567208 |
| 31 | Onycholysis (HP:0001806) | 3.47513756 |
| 32 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.43499606 |
| 33 | Mucopolysacchariduria (HP:0008155) | 3.43499606 |
| 34 | Diaphragmatic weakness (HP:0009113) | 3.23676922 |
| 35 | Oral leukoplakia (HP:0002745) | 3.20095857 |
| 36 | Orchitis (HP:0100796) | 3.19641504 |
| 37 | Mutism (HP:0002300) | 3.18452527 |
| 38 | Prolonged bleeding time (HP:0003010) | 3.11436828 |
| 39 | Abnormality of iron homeostasis (HP:0011031) | 3.02702202 |
| 40 | Autoimmune thrombocytopenia (HP:0001973) | 2.98879302 |
| 41 | Myocardial infarction (HP:0001658) | 2.97083112 |
| 42 | Glomerulonephritis (HP:0000099) | 2.96876713 |
| 43 | Retrobulbar optic neuritis (HP:0100654) | 2.94958782 |
| 44 | Optic neuritis (HP:0100653) | 2.94958782 |
| 45 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.94811029 |
| 46 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.89470023 |
| 47 | Macrocytic anemia (HP:0001972) | 2.84395100 |
| 48 | Chromsome breakage (HP:0040012) | 2.82970892 |
| 49 | Cerebral inclusion bodies (HP:0100314) | 2.81719308 |
| 50 | Myositis (HP:0100614) | 2.76695170 |
| 51 | Recurrent bacterial skin infections (HP:0005406) | 2.72092663 |
| 52 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.69764292 |
| 53 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.69764292 |
| 54 | Apathy (HP:0000741) | 2.69456646 |
| 55 | Purpura (HP:0000979) | 2.69396742 |
| 56 | Duplicated collecting system (HP:0000081) | 2.63080849 |
| 57 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.58909077 |
| 58 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.58387771 |
| 59 | Diminished motivation (HP:0000745) | 2.58255872 |
| 60 | Abnormality of the preputium (HP:0100587) | 2.52558174 |
| 61 | Prolonged neonatal jaundice (HP:0006579) | 2.49863263 |
| 62 | Complement deficiency (HP:0004431) | 2.49699373 |
| 63 | Upper motor neuron abnormality (HP:0002127) | 2.46388770 |
| 64 | Metaphyseal irregularity (HP:0003025) | 2.45596531 |
| 65 | Amyloidosis (HP:0011034) | 2.45568807 |
| 66 | Thin bony cortex (HP:0002753) | 2.42187241 |
| 67 | Breast hypoplasia (HP:0003187) | 2.40935655 |
| 68 | Recurrent abscess formation (HP:0002722) | 2.40546741 |
| 69 | Hyperbilirubinemia (HP:0002904) | 2.38602627 |
| 70 | Premature rupture of membranes (HP:0001788) | 2.36171787 |
| 71 | Stomatitis (HP:0010280) | 2.35454517 |
| 72 | Polycythemia (HP:0001901) | 2.35099435 |
| 73 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.34318104 |
| 74 | Cutaneous photosensitivity (HP:0000992) | 2.32334122 |
| 75 | Progressive neurologic deterioration (HP:0002344) | 2.31906385 |
| 76 | Mediastinal lymphadenopathy (HP:0100721) | 2.29309347 |
| 77 | Eczematoid dermatitis (HP:0000976) | 2.29006878 |
| 78 | Neuronal loss in central nervous system (HP:0002529) | 2.28870806 |
| 79 | Interstitial pulmonary disease (HP:0006530) | 2.28104119 |
| 80 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.27948405 |
| 81 | Abnormality of the renal collecting system (HP:0004742) | 2.26116250 |
| 82 | Selective tooth agenesis (HP:0001592) | 2.25802434 |
| 83 | Achilles tendon contracture (HP:0001771) | 2.25673569 |
| 84 | Hematochezia (HP:0002573) | 2.25221049 |
| 85 | Rough bone trabeculation (HP:0100670) | 2.24772606 |
| 86 | Fragile skin (HP:0001030) | 2.23602135 |
| 87 | Abnormality of complement system (HP:0005339) | 2.23481505 |
| 88 | Protrusio acetabuli (HP:0003179) | 2.23466637 |
| 89 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.23117985 |
| 90 | Cervical subluxation (HP:0003308) | 2.22362653 |
| 91 | Microretrognathia (HP:0000308) | 2.21791989 |
| 92 | Small intestinal stenosis (HP:0012848) | 2.20146050 |
| 93 | Duodenal stenosis (HP:0100867) | 2.20146050 |
| 94 | Sparse eyelashes (HP:0000653) | 2.19839417 |
| 95 | Type I transferrin isoform profile (HP:0003642) | 2.18230079 |
| 96 | Meckel diverticulum (HP:0002245) | 2.17565804 |
| 97 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.13262902 |
| 98 | Upper limb muscle weakness (HP:0003484) | 2.11975956 |
| 99 | Spondylolisthesis (HP:0003302) | 2.11846511 |
| 100 | Ileus (HP:0002595) | 2.10700129 |
| 101 | Increased serum lactate (HP:0002151) | 2.10115664 |
| 102 | 3-Methylglutaconic aciduria (HP:0003535) | 2.09712812 |
| 103 | Vertebral compression fractures (HP:0002953) | 2.07935350 |
| 104 | Pancytopenia (HP:0001876) | 2.07858029 |
| 105 | Abnormality of the Achilles tendon (HP:0005109) | 2.06845539 |
| 106 | Malnutrition (HP:0004395) | 2.06660147 |
| 107 | Reduced antithrombin III activity (HP:0001976) | 2.06576455 |
| 108 | Abnormality of the ileum (HP:0001549) | 2.06483516 |
| 109 | Mitochondrial inheritance (HP:0001427) | 2.05471037 |
| 110 | Poor head control (HP:0002421) | 2.05451823 |
| 111 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 2.03615186 |
| 112 | Abnormal blistering of the skin (HP:0008066) | 2.03468304 |
| 113 | Abnormality of dental color (HP:0011073) | 2.02041451 |
| 114 | Epistaxis (HP:0000421) | 2.00885681 |
| 115 | Asymmetric septal hypertrophy (HP:0001670) | 2.00119877 |
| 116 | Joint stiffness (HP:0001387) | 2.00016167 |
| 117 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 11.9106278 |
| 118 | Hepatosplenomegaly (HP:0001433) | 1.98998106 |
| 119 | Keratoconjunctivitis sicca (HP:0001097) | 1.98662450 |
| 120 | Bone pain (HP:0002653) | 1.97865673 |
| 121 | Dementia (HP:0000726) | 1.97631067 |
| 122 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.97250152 |
| 123 | Pathologic fracture (HP:0002756) | 1.97186216 |
| 124 | Myelodysplasia (HP:0002863) | 1.97102195 |
| 125 | Mesangial abnormality (HP:0001966) | 1.95729202 |
| 126 | Increased IgE level (HP:0003212) | 1.94675917 |
| 127 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.94645983 |
| 128 | Increased CSF lactate (HP:0002490) | 1.93556705 |
| 129 | Acute necrotizing encephalopathy (HP:0006965) | 1.92082291 |
| 130 | Hepatocellular necrosis (HP:0001404) | 1.91836912 |
| 131 | Thick nail (HP:0001805) | 1.91151675 |
| 132 | Inappropriate behavior (HP:0000719) | 1.90938848 |
| 133 | Hyperalaninemia (HP:0003348) | 1.90558069 |
| 134 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.90558069 |
| 135 | Abnormality of alanine metabolism (HP:0010916) | 1.90558069 |
| 136 | Personality changes (HP:0000751) | 1.89410959 |
| 137 | Pulmonary infiltrates (HP:0002113) | 1.89370087 |
| 138 | Trismus (HP:0000211) | 1.89241016 |
| 139 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.88691351 |
| 140 | Supranuclear gaze palsy (HP:0000605) | 1.88444546 |
| 141 | Nonimmune hydrops fetalis (HP:0001790) | 1.87707344 |
| 142 | Abnormality of chromosome stability (HP:0003220) | 1.87226679 |
| 143 | Parakeratosis (HP:0001036) | 1.86291227 |
| 144 | Nausea (HP:0002018) | 1.86228773 |
| 145 | Basal ganglia calcification (HP:0002135) | 1.85489796 |
| 146 | Microvesicular hepatic steatosis (HP:0001414) | 1.85383534 |
| 147 | Slender long bone (HP:0003100) | 1.85041403 |
| 148 | 11 pairs of ribs (HP:0000878) | 1.83575819 |
| 149 | Tetraparesis (HP:0002273) | 1.82623988 |
| 150 | Atrophic scars (HP:0001075) | 1.82573576 |
| 151 | Secondary amenorrhea (HP:0000869) | 1.82465772 |
| 152 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.81060190 |
| 153 | Zonular cataract (HP:0010920) | 1.80665892 |
| 154 | Redundant skin (HP:0001582) | 1.80415098 |
| 155 | Agnosia (HP:0010524) | 1.80291591 |
| 156 | Natal tooth (HP:0000695) | 1.80250644 |
| 157 | Exertional dyspnea (HP:0002875) | 1.78492611 |
| 158 | Patellar aplasia (HP:0006443) | 1.77569021 |
| 159 | Severe visual impairment (HP:0001141) | 1.76840392 |
| 160 | J-shaped sella turcica (HP:0002680) | 1.76828206 |
| 161 | Cerebral aneurysm (HP:0004944) | 1.76714164 |
| 162 | Hypoplasia of the pons (HP:0012110) | 1.76651231 |
| 163 | Hyperparathyroidism (HP:0000843) | 1.75724556 |
| 164 | Conjunctival telangiectasia (HP:0000524) | 1.75427005 |
| 165 | Abnormality of the nasal mucosa (HP:0000433) | 1.75349066 |
| 166 | Abnormality of the pons (HP:0007361) | 1.75159075 |
| 167 | Type 2 muscle fiber atrophy (HP:0003554) | 1.74862123 |
| 168 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.73979455 |
| 169 | Ovoid vertebral bodies (HP:0003300) | 1.73397896 |
| 170 | Keratoconjunctivitis (HP:0001096) | 1.73364196 |
| 171 | Nephritis (HP:0000123) | 1.71455120 |
| 172 | Thoracic kyphosis (HP:0002942) | 1.70750212 |
| 173 | Muscle fiber atrophy (HP:0100295) | 1.69302320 |
| 174 | Abnormality of DNA repair (HP:0003254) | 1.68423244 |
| 175 | Increased IgM level (HP:0003496) | 1.68287308 |
| 176 | Paralysis (HP:0003470) | 1.68197036 |
| 177 | Tongue fasciculations (HP:0001308) | 1.68030650 |
| 178 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.67733996 |
| 179 | Gangrene (HP:0100758) | 1.67093362 |
| 180 | Abnormal trabecular bone morphology (HP:0100671) | 1.66809305 |
| 181 | Chronic otitis media (HP:0000389) | 1.66787003 |
| 182 | Polyneuropathy (HP:0001271) | 1.66713833 |
| 183 | Short 5th finger (HP:0009237) | 1.66455751 |
| 184 | Microcytic anemia (HP:0001935) | 1.65414145 |
| 185 | Abnormal protein glycosylation (HP:0012346) | 1.64701444 |
| 186 | Abnormal glycosylation (HP:0012345) | 1.64701444 |
| 187 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.64701444 |
| 188 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.64701444 |
| 189 | Peripheral demyelination (HP:0011096) | 1.63444032 |
| 190 | Chronic obstructive pulmonary disease (HP:0006510) | 1.61794401 |
| 191 | Obstructive lung disease (HP:0006536) | 1.61794401 |
| 192 | Femoral bowing (HP:0002980) | 1.61336470 |
| 193 | Flared iliac wings (HP:0002869) | 1.60882086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.65257269 |
| 2 | EIF2AK1 | 3.82770909 |
| 3 | PIM2 | 3.79709353 |
| 4 | DDR2 | 3.44804197 |
| 5 | STK16 | 2.80199946 |
| 6 | VRK1 | 2.73366992 |
| 7 | GRK7 | 2.73348920 |
| 8 | RIPK1 | 2.70772144 |
| 9 | WEE1 | 2.53306256 |
| 10 | CDC7 | 2.38088360 |
| 11 | DYRK3 | 2.28134541 |
| 12 | BUB1 | 2.16011241 |
| 13 | ERN1 | 2.14331478 |
| 14 | MATK | 2.14026514 |
| 15 | RPS6KA4 | 2.13876832 |
| 16 | SCYL2 | 2.04763453 |
| 17 | MOS | 2.04229040 |
| 18 | ACVR1B | 1.83683432 |
| 19 | BRSK2 | 1.76914938 |
| 20 | IRAK3 | 1.76144401 |
| 21 | ZAK | 1.71687110 |
| 22 | PDGFRA | 1.70439741 |
| 23 | FGR | 1.63134843 |
| 24 | CDC42BPA | 1.61278199 |
| 25 | NEK2 | 1.60763922 |
| 26 | SRPK1 | 1.60348329 |
| 27 | PRPF4B | 1.59979496 |
| 28 | LATS2 | 1.55534944 |
| 29 | FLT3 | 1.54863642 |
| 30 | NME1 | 1.51406549 |
| 31 | TNIK | 1.49694446 |
| 32 | IRAK4 | 1.47658394 |
| 33 | EIF2AK3 | 1.42878694 |
| 34 | MAP3K11 | 1.41832752 |
| 35 | TESK1 | 1.41520994 |
| 36 | TGFBR2 | 1.40911539 |
| 37 | CDK19 | 1.39023335 |
| 38 | MST4 | 1.35824506 |
| 39 | CSK | 1.33553008 |
| 40 | PBK | 1.31459294 |
| 41 | KDR | 1.28509758 |
| 42 | TLK1 | 1.28129681 |
| 43 | ABL2 | 1.27941265 |
| 44 | EIF2AK2 | 1.27870952 |
| 45 | MKNK1 | 1.26734059 |
| 46 | MAPKAPK5 | 1.25918121 |
| 47 | ICK | 1.25115642 |
| 48 | TRIB3 | 1.24850481 |
| 49 | AURKB | 1.17605385 |
| 50 | PIM1 | 1.17500656 |
| 51 | ARAF | 1.15116462 |
| 52 | TTN | 1.14867126 |
| 53 | JAK3 | 1.14824116 |
| 54 | IKBKB | 1.14135391 |
| 55 | SIK1 | 1.12301504 |
| 56 | ATR | 1.12101601 |
| 57 | EPHB2 | 1.11018323 |
| 58 | MKNK2 | 1.10716374 |
| 59 | MAP2K3 | 1.08617773 |
| 60 | KIT | 1.07572385 |
| 61 | MAP3K3 | 1.07364267 |
| 62 | TYRO3 | 1.04739675 |
| 63 | TTK | 1.04472707 |
| 64 | MAP3K1 | 1.03786640 |
| 65 | PLK1 | 1.02724467 |
| 66 | CDK7 | 1.02552828 |
| 67 | ZAP70 | 1.02493485 |
| 68 | TEC | 1.00218220 |
| 69 | STK10 | 0.99359383 |
| 70 | MAP3K14 | 0.98767966 |
| 71 | TBK1 | 0.96793367 |
| 72 | BRAF | 0.95100824 |
| 73 | ADRBK2 | 0.94820095 |
| 74 | TYK2 | 0.94564270 |
| 75 | CDK8 | 0.94230839 |
| 76 | MAP3K13 | 0.93135051 |
| 77 | NEK1 | 0.92317608 |
| 78 | RIPK4 | 0.91507379 |
| 79 | MAP4K1 | 0.91327487 |
| 80 | BRSK1 | 0.90895709 |
| 81 | LRRK2 | 0.89471708 |
| 82 | PIK3CG | 0.87736193 |
| 83 | PLK4 | 0.87684893 |
| 84 | NUAK1 | 0.87682379 |
| 85 | STK4 | 0.87608638 |
| 86 | IRAK2 | 0.86875624 |
| 87 | AURKA | 0.86383760 |
| 88 | RPS6KB2 | 0.85838161 |
| 89 | TESK2 | 0.84229274 |
| 90 | BMPR2 | 0.83227144 |
| 91 | TSSK6 | 0.78893491 |
| 92 | MAP3K8 | 0.77528844 |
| 93 | BMX | 0.76849837 |
| 94 | MAPKAPK3 | 0.75811661 |
| 95 | TAOK2 | 0.73982559 |
| 96 | BLK | 0.72026251 |
| 97 | IKBKE | 0.68905857 |
| 98 | LIMK1 | 0.67626160 |
| 99 | RAF1 | 0.67180558 |
| 100 | NEK9 | 0.65136997 |
| 101 | CSNK2A1 | 0.64723524 |
| 102 | TGFBR1 | 0.63919750 |
| 103 | TIE1 | 0.62524087 |
| 104 | PTK2 | 0.61544203 |
| 105 | GRK1 | 0.61371673 |
| 106 | TRPM7 | 0.61217787 |
| 107 | EPHA2 | 0.60649898 |
| 108 | RPS6KA5 | 0.60213860 |
| 109 | CSF1R | 0.59928822 |
| 110 | PAK4 | 0.57757782 |
| 111 | ATM | 0.57756807 |
| 112 | STK24 | 0.57702333 |
| 113 | CDK4 | 0.56641239 |
| 114 | MAP2K6 | 0.56288086 |
| 115 | CCNB1 | 0.55130886 |
| 116 | PDGFRB | 0.54441330 |
| 117 | RPS6KL1 | 0.54000327 |
| 118 | RPS6KC1 | 0.54000327 |
| 119 | DAPK3 | 0.53886010 |
| 120 | IRAK1 | 0.53702040 |
| 121 | CSNK2A2 | 0.53438968 |
| 122 | CLK1 | 0.53422211 |
| 123 | CHEK2 | 0.52438715 |
| 124 | MUSK | 0.51807381 |
| 125 | STK3 | 0.50983088 |
| 126 | TAOK1 | 0.50463168 |
| 127 | CHUK | 0.49503685 |
| 128 | RPS6KA2 | 0.48015543 |
| 129 | EPHB1 | 0.47219458 |
| 130 | FGFR4 | 0.47094908 |
| 131 | MAPKAPK2 | 0.46701056 |
| 132 | MAP3K6 | 0.46542377 |
| 133 | PRKD2 | 0.46125447 |
| 134 | TAOK3 | 0.45948209 |
| 135 | JAK1 | 0.45575376 |
| 136 | MAP3K5 | 0.45204490 |
| 137 | CDK6 | 0.45145958 |
| 138 | LYN | 0.44781751 |
| 139 | JAK2 | 0.43670091 |
| 140 | CHEK1 | 0.42500267 |
| 141 | YES1 | 0.42028113 |
| 142 | RPS6KA6 | 0.41664836 |
| 143 | MAPK4 | 0.40114087 |
| 144 | GSK3A | 0.39220788 |
| 145 | PRKG2 | 0.39213925 |
| 146 | TXK | 0.38894958 |
| 147 | EPHA3 | 0.38230354 |
| 148 | MAP2K7 | 0.38217384 |
| 149 | TNK2 | 0.37642670 |
| 150 | PAK2 | 0.37431313 |
| 151 | PRKCI | 0.37116962 |
| 152 | PDPK1 | 0.35195376 |
| 153 | MARK3 | 0.34416364 |
| 154 | LCK | 0.33798373 |
| 155 | SYK | 0.33142888 |
| 156 | SIK3 | 0.31055183 |
| 157 | PAK1 | 0.30560519 |
| 158 | HIPK2 | 0.30366710 |
| 159 | MYLK | 0.29727579 |
| 160 | MST1R | 0.28428950 |
| 161 | SMG1 | 0.25748443 |
| 162 | HCK | 0.25403334 |
| 163 | CAMKK2 | 0.24203152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.81667082 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.09393423 |
| 3 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 3.46298154 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.20355135 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.99803963 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.98810004 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.96433395 |
| 8 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.68526800 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.67591918 |
| 10 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.58967301 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.54967811 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.51693262 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.51380173 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 2.45019895 |
| 15 | Spliceosome_Homo sapiens_hsa03040 | 2.30029483 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.15173134 |
| 17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.02241173 |
| 18 | Salmonella infection_Homo sapiens_hsa05132 | 1.99901562 |
| 19 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.98281482 |
| 20 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.97642227 |
| 21 | Cell cycle_Homo sapiens_hsa04110 | 1.90630936 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.90342742 |
| 23 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.90067364 |
| 24 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.84162587 |
| 25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.78894091 |
| 26 | Prion diseases_Homo sapiens_hsa05020 | 1.75015927 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.69113983 |
| 28 | RNA transport_Homo sapiens_hsa03013 | 1.69108115 |
| 29 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.62095993 |
| 30 | Parkinsons disease_Homo sapiens_hsa05012 | 1.59667998 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.57448329 |
| 32 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.50132054 |
| 33 | Purine metabolism_Homo sapiens_hsa00230 | 1.46461587 |
| 34 | Basal transcription factors_Homo sapiens_hsa03022 | 1.38735848 |
| 35 | Sulfur relay system_Homo sapiens_hsa04122 | 1.38726106 |
| 36 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.37000816 |
| 37 | Protein export_Homo sapiens_hsa03060 | 1.36537457 |
| 38 | RNA degradation_Homo sapiens_hsa03018 | 1.36504284 |
| 39 | Phagosome_Homo sapiens_hsa04145 | 1.32716811 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.30518420 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.29189581 |
| 42 | Huntingtons disease_Homo sapiens_hsa05016 | 1.24846183 |
| 43 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.22438013 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.19547810 |
| 45 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.13263527 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 1.12161353 |
| 47 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.11133164 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.10209871 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.06056415 |
| 50 | Malaria_Homo sapiens_hsa05144 | 1.01152102 |
| 51 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.94827876 |
| 52 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.93348948 |
| 53 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.92442931 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.91679147 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 0.91274664 |
| 56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.89728226 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89567561 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.88743793 |
| 59 | Legionellosis_Homo sapiens_hsa05134 | 0.88482260 |
| 60 | Alzheimers disease_Homo sapiens_hsa05010 | 0.87979319 |
| 61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.86910636 |
| 62 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.86581429 |
| 63 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.86364517 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86288525 |
| 65 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86124393 |
| 66 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85944314 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.84211038 |
| 68 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.81808075 |
| 69 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81564167 |
| 70 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.81548295 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.76990998 |
| 72 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.75143023 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74464623 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.74384951 |
| 75 | Bladder cancer_Homo sapiens_hsa05219 | 0.70589089 |
| 76 | Measles_Homo sapiens_hsa05162 | 0.69321223 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68850035 |
| 78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.68618223 |
| 79 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68286496 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65710851 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65525329 |
| 82 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65494005 |
| 83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.64673649 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.64216524 |
| 85 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63406958 |
| 86 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60652889 |
| 87 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60582570 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59887543 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59738375 |
| 90 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59254010 |
| 91 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58392199 |
| 92 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57295673 |
| 93 | Hepatitis B_Homo sapiens_hsa05161 | 0.56797617 |
| 94 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56507530 |
| 95 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.55969305 |
| 96 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55619616 |
| 97 | Leishmaniasis_Homo sapiens_hsa05140 | 0.54239013 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53652729 |
| 99 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.52840724 |
| 100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52733940 |
| 101 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.51312375 |
| 102 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50526163 |
| 103 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49534977 |
| 104 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.49158304 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.47880997 |
| 106 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47528977 |
| 107 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46381216 |
| 108 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46083825 |
| 109 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.45991472 |
| 110 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45130940 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44545947 |
| 112 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44525316 |
| 113 | Influenza A_Homo sapiens_hsa05164 | 0.44508753 |
| 114 | Focal adhesion_Homo sapiens_hsa04510 | 0.43915790 |
| 115 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.43412687 |
| 116 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43225104 |
| 117 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.42427736 |
| 118 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.41419332 |
| 119 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.36661761 |
| 120 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34760935 |
| 121 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.34524433 |
| 122 | Allograft rejection_Homo sapiens_hsa05330 | 0.34513804 |
| 123 | Pertussis_Homo sapiens_hsa05133 | 0.33481033 |
| 124 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.33404496 |
| 125 | Shigellosis_Homo sapiens_hsa05131 | 0.32837105 |
| 126 | * Tuberculosis_Homo sapiens_hsa05152 | 0.31114388 |
| 127 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.30847796 |
| 128 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30411355 |
| 129 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.30382974 |
| 130 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.30028061 |
| 131 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.28804317 |
| 132 | Insulin resistance_Homo sapiens_hsa04931 | 0.28295078 |
| 133 | ABC transporters_Homo sapiens_hsa02010 | 0.28149973 |
| 134 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.27847043 |
| 135 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.27672224 |
| 136 | Other glycan degradation_Homo sapiens_hsa00511 | 0.26677990 |
| 137 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.26561793 |
| 138 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.26350297 |
| 139 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25736348 |
| 140 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25633796 |
| 141 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.24757348 |
| 142 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.24704186 |
| 143 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.24621282 |
| 144 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23989423 |
| 145 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.23717110 |
| 146 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.23382810 |
| 147 | Thyroid cancer_Homo sapiens_hsa05216 | 0.23318280 |
| 148 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.22491153 |
| 149 | Asthma_Homo sapiens_hsa05310 | 0.21957867 |
| 150 | Amoebiasis_Homo sapiens_hsa05146 | 0.21305910 |
| 151 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.19056213 |
| 152 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.17395026 |
| 153 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.17268837 |

